NVDAVSRXRX• 28 Days (Normalized)
NVDA vs RXRX (NVIDIA Corporation vs Recursion Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NVDA Performance $237.47
+8.75%
NVIDIA Corporation
Normalized Baseline0.00%
RXRX Performance $4.27
+35.13%
Recursion Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin RXRX LEADS
-26.38 pts
RXRX outperforming by 26.38 percentage points
NVDARXRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NVDA RXRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | NVDA Price | NVDA Gain (%) | RXRX Price | RXRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $237.47 | +8.75% | $4.27 | +35.13% | -26.38% |
| Oct 06, 2026 | $239.24 | +9.56% | $4.63 | +46.52% | -36.96% |
| Oct 05, 2026 | $238.90 | +9.41% | $4.78 | +51.27% | -41.86% |
| Oct 02, 2026 | $233.95 | +7.14% | $4.12 | +30.38% | -23.24% |
| Oct 01, 2026 | $230.86 | +5.72% | $4.07 | +28.80% | -23.08% |
| Sep 30, 2026 | $228.38 | +4.59% | $4.13 | +30.70% | -26.11% |
| Sep 29, 2026 | $227.21 | +4.05% | $4.03 | +27.53% | -23.48% |
| Sep 28, 2026 | $228.86 | +4.81% | $3.70 | +17.09% | -12.28% |
| Sep 25, 2026 | $225.07 | +3.07% | $3.74 | +18.35% | -15.28% |
| Sep 24, 2026 | $224.58 | +2.85% | $3.89 | +23.10% | -20.25% |
| Sep 23, 2026 | $225.51 | +3.27% | $3.70 | +17.09% | -13.82% |
| Sep 22, 2026 | $228.87 | +4.81% | $4.05 | +28.16% | -23.35% |
| Sep 21, 2026 | $227.38 | +4.13% | $3.97 | +25.63% | -21.50% |
| Sep 18, 2026 | $222.27 | +1.79% | $3.83 | +21.20% | -19.41% |
| Sep 17, 2026 | $219.34 | +0.45% | $3.54 | +12.03% | -11.58% |
Page 1 of 2